AAAAAA

   
Results: 1-12 |
Results: 12
Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein
Authors: Andersen, OM Petersen, HH Jacobsen, C Moestrup, SK Etzerodt, M Andreasen, PA Thogersen, HC
Citation: Om. Andersen et al., Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein, BIOCHEM J, 357, 2001, pp. 289-296
A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands - Ligand-induced serpin polymerization
Authors: Egelund, R Einholm, AP Pedersen, KE Nielsen, RW Christensen, A Deinum, J Andreasen, PA
Citation: R. Egelund et al., A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands - Ligand-induced serpin polymerization, J BIOL CHEM, 276(16), 2001, pp. 13077-13086
Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 - Implications for antibody-mediated PAI-1-neutralization and vitronectin-binding
Authors: Wind, T Jensen, MA Andreasen, PA
Citation: T. Wind et al., Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 - Implications for antibody-mediated PAI-1-neutralization and vitronectin-binding, EUR J BIOCH, 268(4), 2001, pp. 1095-1106
A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism
Authors: Egelund, R Petersen, TE Andreasen, PA
Citation: R. Egelund et al., A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism, EUR J BIOCH, 268(3), 2001, pp. 673-685
Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms
Authors: Hansen, M Busse, MN Andreasen, PA
Citation: M. Hansen et al., Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms, EUR J BIOCH, 268(23), 2001, pp. 6274-6283
Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator - Relationship between epitope localization and effects ofantibodies on molecular interactions of the enzyme
Authors: Petersen, HH Hansen, M Schousboe, SL Andreasen, PA
Citation: Hh. Petersen et al., Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator - Relationship between epitope localization and effects ofantibodies on molecular interactions of the enzyme, EUR J BIOCH, 268(16), 2001, pp. 4430-4439
The plasminogen activation system in tumor growth, invasion, and metastasis
Authors: Andreasen, PA Egelund, R Petersen, HH
Citation: Pa. Andreasen et al., The plasminogen activation system in tumor growth, invasion, and metastasis, CELL MOL L, 57(1), 2000, pp. 25-40
Vitronectin and substitution at a beta-strand 5A lysine residue potentiateactivity-neutralization of PA inhibitor-1 by monoclonal antibodies againstalpha-helix F
Authors: Schousboe, SL Egelund, R Kirkegaard, T Preissner, KT Rodenburg, KW Andreasen, PA
Citation: Sl. Schousboe et al., Vitronectin and substitution at a beta-strand 5A lysine residue potentiateactivity-neutralization of PA inhibitor-1 by monoclonal antibodies againstalpha-helix F, THROMB HAEM, 83(5), 2000, pp. 742-751
Oestradiol and basic fibroblast growth factor stimulate expression of verylow density lipoprotein receptor and plasminogen activator inhibitor-1 in breast carcinoma cell lines
Authors: Madsen, B Martensen, PM Christensen, A Andreasen, PA
Citation: B. Madsen et al., Oestradiol and basic fibroblast growth factor stimulate expression of verylow density lipoprotein receptor and plasminogen activator inhibitor-1 in breast carcinoma cell lines, FIBRINOL PR, 13(1), 1999, pp. 15-25
Solvent effects on activity and conformation of plasminogen activator inhibitor-1
Authors: Andreasen, PA Egelund, R Jensen, S Rodenburg, KW
Citation: Pa. Andreasen et al., Solvent effects on activity and conformation of plasminogen activator inhibitor-1, THROMB HAEM, 81(3), 1999, pp. 407-414
Ligand binding properties of the very low density lipoprotein receptor - Absence of the third complement-type repeat encoded by exon 4 is associated with reduced binding of M-r 40,000 receptor-associated protein
Authors: Rettenberger, PM Oka, K Ellgaard, L Petersen, HH Christensen, A Martensen, PM Monard, D Etzerodt, M Chan, L Andreasen, PA
Citation: Pm. Rettenberger et al., Ligand binding properties of the very low density lipoprotein receptor - Absence of the third complement-type repeat encoded by exon 4 is associated with reduced binding of M-r 40,000 receptor-associated protein, J BIOL CHEM, 274(13), 1999, pp. 8973-8980
Engineering of conformations of plasminogen activator inhibitor-1 - A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms
Authors: Kirkegaard, T Jensen, S Schousboe, SL Petersen, HH Egelund, R Andreasen, PA Rodenburg, KW
Citation: T. Kirkegaard et al., Engineering of conformations of plasminogen activator inhibitor-1 - A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms, EUR J BIOCH, 263(2), 1999, pp. 577-586
Risultati: 1-12 |